Our Focus
The Colorado Chapter of the National Bleeding Disorders Foundation (NBDF Colorado) is responsible for addressing the challenges bleeding disorder patients and their families face through education, advocacy, and empowerment.
El Capítulo de Colorado de la Fundación Nacional de Trastornos Hemorrágicos (NBDF Colorado) es responsable de abordar los desafíos que enfrentan los pacientes con trastornos hemorrágicos y sus familias a través de la educación, la defensa y el empoderamiento.
Our Mission ... In Action
-
We connect people in the bleeding disorder community to available, applicable resources and to one another. Through connection we don't have to go through this alone.
-
We fight to protect access to quality healthcare and treatments we need to live healthy lives, but we can't do it without your voice. Discover how you and your family can make a big difference by joining our advocacy efforts.
-
We are committed to trailblazing the way for those affected by bleeding disorders. We encourage our community members to step out into nature, to forage ahead on their own path of independence.
-
We are committed to educating people inside and outside the bleeding disorder community. Education is empowerment and we strive to encourage independence through learning.
News Articles
Keri Norris, PhD, JM, MPH, MCHES, Senior Vice President, Health Access and Strategic Innovation, of the National Bleeding Disorders Foundation is a Fierce DEI Award Finalist in the Leadership in Health Equity Category
Dr. Norris has been recognized for her transformative work advancing health access in the inheritable blood and bleeding disorders community.
Because May is Mental Health Awareness Month, the Neil Frick Resource Center (NFRC) is dedicating its most recent Resource Round Up (formerly HANDI Highlights) to supporting mental well-being. This edition approaches this vital topic from a variety of perspectives, with information delivered through multiple formats, including videos, articles, referral resources, and podcasts.
Through investment and partnership, Pathway to Cures encourages early-stage biotech companies to develop treatments that have the potential to improve the lives of people in our community.
Since Pathway to Cures (P2C) launched in 2023, more than 200 early-stage biotechnology, pharma, medical device and diagnostic companies, with innovative approaches that address unmet needs in our blood and bleeding disorders community, have been reviewed by our team.
